LANCET report Covaxin shows 50% effectiveness against symptomatic COVID-19
The results of an interim study recently published in The Lancet showed that two doses of Covaxin,...
Read Moreby Splco Reporter | Nov 24, 2021 | Corona Virus, Health, India, medical | 0 |
The results of an interim study recently published in The Lancet showed that two doses of Covaxin,...
Read Moreby Splco Reporter | Jun 23, 2021 | Companies, Corona Virus, India, medical, Regulators | 0 |
Bharat Biotech, the manufacturer of Covaxin, has submitted its phase-3 clinical trial to the...
Read Moreby Splco Reporter | Jun 2, 2021 | India | 0 |
A Bench of Justices DY Chandrachud, L Nageswara Rao and Ravindra Bhat, in its judgment in the suo...
Read Moreby Splco Reporter | Mar 12, 2021 | Corona Virus, Health, India, Life Science, medical | 0 |
Bharat Biotech’s COVID-19 vaccine, Covaxin, will no longer have to carry the ‘clinical...
Read Moreby Splco Reporter | Jan 19, 2021 | Life Style, Companies, Corona Virus, India, Life Science, medical | 0 |
The move to include Covaxin even before the publication of data from its phase 3 trial had come...
Read Moreby Splco Reporter | Nov 29, 2020 | Protest, Corona Virus, India, Life Science, medical | 0 |
A 40-year-old man who volunteered for ‘Covishield’, vaccine being tested by Pune-based Serum...
Read Moreby Splco Reporter | Jul 20, 2020 | Health, Corona Virus, India, Life Science, medical | 0 |
India saw a record single-day jump of 40,425 COVID-19 cases, pushing its tally past the 11-lakh...
Read More